Liraglutide

Drug Details

Liraglutide, marketed as Victoza, is an injectable medication used to manage Type 2 diabetes in individuals aged 10 and older. It effectively lowers blood sugar levels when combined with a proper diet and exercise regimen. Additionally, for adults with Type 2 diabetes who also have heart disease, it reduces the risk of serious heart-related events like heart attacks and strokes. Liraglutide belongs to a class of drugs known as GLP-1 agonists. It mimics the action of a natural hormone in the body, promoting the release of insulin in response to elevated blood sugar levels, such as those seen after eating. It also helps by reducing the amount of sugar produced by the liver and slowing down digestion. It is important to note that Liraglutide is not a replacement for insulin in patients who require insulin therapy. While generally effective, it may cause side effects such as nausea, vomiting, diarrhea, and constipation. Always consult with a healthcare professional before starting any new medication regimen.